19106767

Source:http://linkedlifedata.com/resource/pubmed/id/19106767

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008059, umls-concept:C0008976, umls-concept:C0012634, umls-concept:C0030685, umls-concept:C0079466, umls-concept:C0205653, umls-concept:C0231449, umls-concept:C0391871, umls-concept:C0424295, umls-concept:C0680255, umls-concept:C1283071, umls-concept:C1963578
pubmed:issue	2
pubmed:dateCreated	2009-12-30
pubmed:abstractText	This study compared the efficacy of guanfacine extended release (GXR), a selective alpha(2A)-adrenoceptor agonist, with placebo in children and adolescents with attention-deficit/hyperactivity disorder (ADHD).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8704565
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Guanfacine, http://linkedlifedata.com/resource/pubmed/chemical/Placebos
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1527-5418
pubmed:author	pubmed-author:BiedermanJosephJ, pubmed-author:DonahueJessicaJ, pubmed-author:LyneAndrewA, pubmed-author:McGoughJamesJ, pubmed-author:SPD503 STUDY GROUP, pubmed-author:SalleeFloyd RFR, pubmed-author:WigalTimT
pubmed:issnType	Electronic
pubmed:volume	48
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	155-65
pubmed:meshHeading	pubmed-meshheading:19106767-Adolescent, pubmed-meshheading:19106767-Adrenergic alpha-Agonists, pubmed-meshheading:19106767-Attention Deficit Disorder with Hyperactivity, pubmed-meshheading:19106767-Blood Pressure, pubmed-meshheading:19106767-Child, pubmed-meshheading:19106767-Dose-Response Relationship, Drug, pubmed-meshheading:19106767-Double-Blind Method, pubmed-meshheading:19106767-Drug Administration Schedule, pubmed-meshheading:19106767-Drug Delivery Systems, pubmed-meshheading:19106767-Female, pubmed-meshheading:19106767-Guanfacine, pubmed-meshheading:19106767-Heart Rate, pubmed-meshheading:19106767-Humans, pubmed-meshheading:19106767-Male, pubmed-meshheading:19106767-Placebos, pubmed-meshheading:19106767-Psychiatric Status Rating Scales, pubmed-meshheading:19106767-Treatment Outcome
pubmed:year	2009
pubmed:articleTitle	Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial.
pubmed:affiliation	Department of Psychiatry, University of Cincinnati, 231 Albert Sabin Way, ML 0559, Cincinnati, OH 45267, USA. floyd.sallee@uc.edu
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study